4-[[(3R)-3-(2,2,2-trifluoroethylcarbamoyl)piperidin-1-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide
C16H19F3N6O2 — CID 155032790
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[[(3R)-3-(2,2,2-trifluoroethylcarbamoyl)piperidin-1-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide
4-[[(3R)-3-(2,2,2-trifluoroethylcarbamoyl)piperidin-1-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide (PubChem CID 155032790) has the molecular formula C16H19F3N6O2 and a molecular weight of 384.36 g/mol. Its IUPAC name is 4-[[(3R)-3-(2,2,2-trifluoroethylcarbamoyl)piperidin-1-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide.
Molecular Properties
| Compound Name | 4-[[(3R)-3-(2,2,2-trifluoroethylcarbamoyl)piperidin-1-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide |
|---|---|
| PubChem CID | 155032790 |
| Molecular Formula | C16H19F3N6O2 |
| Molecular Weight | 384.36 g/mol |
| Exact Mass | 384.15 |
| IUPAC Name | 4-[[(3R)-3-(2,2,2-trifluoroethylcarbamoyl)piperidin-1-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide |
| SMILES | NC(=O)c1cnc2[nH]ccc2c1NN1CCC[C@@H](C(=O)NCC(F)(F)F)C1 |
| InChI | InChI=1S/C16H19F3N6O2/c17-16(18,19)8-23-15(27)9-2-1-5-25(7-9)24-12-10-3-4-21-14(10)22-6-11(12)13(20)26/h3-4,6,9H,1-2,5,7-8H2,(H2,20,26)(H,23,27)(H2,21,22,24)/t9-/m1/s1 |
| InChIKey | VOOWQKFHYGNEJR-SECBINFHSA-N |
| XLogP | 1.38 |
| TPSA | 116.14 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 384.36 |
| LogP ≤ 5 | 1.38 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155032790 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.